Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Research progress of Piezo1-mediated mechanical immunity in immune cells].

Created on 11 Nov 2026

Authors

Aizhuo Chen, Yixin Huang, Huazhi Zhang, Zhengtai Zhao, Wen Su

Published in

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. Volume 42. Issue 11. Pages 1038-1043.

Abstract

Mechanical immunity is an emerging research field in recent years that focuses on the interplay between mechanical forces and immune responses. As a mechanosensitive ion channel, Piezo1 can sense mechanical stimuli and modulate immune cells through associated signaling pathways. This review primarily elaborates on the mechanisms underlying the role of Piezo1 in innate and adaptive immune cells. At the level of innate immunity, in macrophages, Piezo1 senses mechanical cues such as extracellular matrix stiffness and cell membrane tension, thereby regulating macrophage polarization, phagocytic and bactericidal activity, and metabolic processes; in dendritic cells (DCs), Piezo1-mediated mechanical signals promote DC maturation and migration, and direct the immune response profile of DCs; in neutrophils (polymorphonuclear leukocytes, PMNs), Piezo1 plays a crucial role in regulating phagocytosis, angiogenesis promotion, and sterile thrombus formation. At the level of adaptive immunity, in CD8+ T cells, Piezo1 enables mechanical force sensing to suppress CD8+ T cell exhaustion, thereby enhancing their tumor-killing functions; in CD4+ T cells, Piezo1 specifically regulates the differentiation of T helper 9 (Th9) cells, providing a potential direction for anti-tumor therapy; in B cells, Piezo1 modulates the proliferation and differentiation of B cells into plasma cells, influences the production of corresponding antibodies, and plays a significant role in immune-related diseases. By reviewing the research on the regulatory mechanisms of Piezo1 in various immune cells, this paper aims to provide reference for the development of novel therapeutic strategies to treat immune-related diseases including autoimmune diseases, tumors and inflammation.

PMID:
43009334
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement